Universal Health Realty Income Trust

UHT | NYSE

Price Alert Chart Builder DCF Calculator

$38.25

+$0.38 (+1.00%)

At close: Oct 30, 2026, 4:00 PM ET

$38.25

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $531.62M

Enterprise Value $932.25M

Beta 0.85

Average Volume 130.81K

Shares Outstanding (Diluted) 13.9M

Shares Change YoY 0.28%

Institutional Ownership 63.43%

Exchange NYSE

ISIN US91359E1055

Price Performance

Price Change 1M 2.3%

Price Change 3M -11.9%

Price Change 6M -5.7%

Price Change YTD -2.5%

Price Change 1Y 0.1%

Price Change 3Y -0.5%

Price Change 5Y -32.9%

1M CAGR (ann.) -2.0%

1Y CAGR (ann.) 13.3%

5Y CAGR (ann.) -1.5%

All-Time CAGR 0.9%

Valuation

PE Ratio 26.20

Forward PE 21.07

PEG Ratio 2.13

Forward PEG 2.74

PS Ratio 3.57

Forward PS 5.00

PB Ratio 3.81

P/FCF Ratio 11.02

P/Adj. FCF Ratio 11.23

P/OCF Ratio 10.99

EV/Sales 6.26

EV/EBIT 25.74

EV/EBITDA 17.08

EV/FCF 19.32

Earnings Yield 3.8%

FCF Yield 9.1%

Adj. FCF Yield 8.9%

Financial Health

Net Debt $389.24M

Total Debt $407.1M

Cash & Short-Term Investments $6.47M

Total Assets $573.01M

Current Ratio 0.00

Quick Ratio 0.00

Debt / Equity Ratio 2.92

Debt / EBITDA 7.46

Debt / FCF 8.44

OCF / Debt 0.12

Interest Coverage 3.35

Altman Z-Score 0.92

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 61.3%

Operating Profit Margin 36.8%

EBITDA Margin 43.0%

Net Profit Margin 13.6%

FCF Margin 32.4%

Adj. FCF Margin 31.8%

SBC / Revenue 0.6%

SBC Impact (per share) -1.9%

Returns

Return on Assets 3.5%

Return on Equity 13.8%

Return on Invested Capital 143.4%

Return on Capital Employed 9.6%

Return on Tangible Assets 3.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 16.0%

Revenue CAGR 5Y 12.5%

Revenue CAGR 10Y 8.6%

EPS CAGR 3Y 5.0%

EPS CAGR 5Y -2.3%

EPS CAGR 10Y 1.3%

FCF CAGR 3Y -5.8%

FCF CAGR 5Y 0.8%

FCF CAGR 10Y 16.8%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 1

EPS Growth Next 3Y 11.0%

Revenue Growth Next 3Y -8.1%

Earnings Date Mar 2, 2027

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) $25.5M

Revenue Growth Est (next Q) 4.2%

Fair Value Estimates

Graham Number $18.19

Graham Upside -52.4%

Lynch Fair Value $7.30

Lynch Upside -80.9%

Price Target $43.00

Price Target Upside 12.4%

Cash Flow

Operating Cash Flow $48.25M

Free Cash Flow $48.25M

Adj. Free Cash Flow $47.35M

FCF Per Share $3.48

OCF Per Share $3.48

OCF/S Ratio 32.4%

Income Statement

Revenue $148.83M

Gross Profit $91.24M

Operating Income $54.81M

EBITDA $54.58M

Net Income $20.18M

EPS (Diluted) $1.46

Revenue / Employee N/A

Profit / Employee N/A

Employees 0

Dividends

Annual Dividend $2.99

Dividend Yield 7.82%

Payout Ratio 204.8%

FCF Payout Ratio 85.7%

Adj. FCF Payout Ratio 87.4%

Dividend Growth (YoY) 1.4%

Pay Frequency Quarterly

Ex-Dividend Date Sep 21, 2026